|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
33,202,000 |
Market
Cap: |
N/A |
Last
Volume: |
655,586 |
Avg
Vol: |
293,782 |
52
Week Range: |
$31.02 - $31.02 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bonadio Tom |
Director |
|
2007-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
21,970 |
|
- |
|
Baker Michael A |
Director |
|
2007-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
11,170 |
|
- |
|
Toni Robert V |
Director |
|
2007-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
60,170 |
|
- |
|
Tunstall Kathryn |
Director |
|
2007-05-09 |
4 |
OE |
$9.63 |
$850,205 |
D/D |
88,333 |
134,277 |
|
- |
|
Tunstall Kathryn |
Director |
|
2007-05-09 |
4 |
S |
$18.00 |
$541,271 |
D/D |
(30,000) |
45,944 |
|
- |
|
Tunstall Kathryn |
Director |
|
2007-05-07 |
4 |
S |
$18.94 |
$694,289 |
D/D |
(36,666) |
75,944 |
|
- |
|
Cote Ulric E III |
VP of Sales |
|
2007-04-10 |
4 |
A |
$0.00 |
$36 |
D/D |
12,000 |
53,071 |
|
- |
|
Tunstall Kathryn |
Director |
|
2007-03-02 |
4 |
S |
$18.10 |
$144,953 |
D/D |
(8,000) |
107,610 |
|
- |
|
Tunstall Kathryn |
Director |
|
2007-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
112,610 |
|
- |
|
Cote Ulric E III |
VP of Sales |
|
2007-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,429 |
44,500 |
|
- |
|
Sieczkarek Mark M |
President/CEO |
|
2007-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
13,400 |
88,329 |
|
- |
|
Sinclair Edward |
VP Clinical Research, Regulat |
|
2007-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,562 |
35,842 |
|
- |
|
Pohmajevich Lisa |
Vice President of Marketing |
|
2007-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,570 |
26,874 |
|
- |
|
Lichtwardt Gregory |
Executive Vice President, CFO |
|
2007-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,691 |
42,171 |
|
- |
|
Pohmajevich Lisa |
Vice President of Marketing |
|
2006-12-29 |
5 |
A |
$11.59 |
$997 |
D/D |
86 |
25,304 |
|
- |
|
Sinclair Edward |
VP Clinical Research, Regulat |
|
2006-12-29 |
5 |
A |
$11.59 |
$4,974 |
D/D |
429 |
34,280 |
|
- |
|
Sieczkarek Mark M |
President/CEO |
|
2006-12-29 |
5 |
A |
$11.59 |
$5,785 |
D/D |
499 |
74,929 |
|
- |
|
Lichtwardt Gregory |
Executive Vice President, CFO |
|
2006-12-29 |
5 |
A |
$10.73 |
$10,330 |
D/D |
963 |
39,480 |
|
- |
|
Cote Ulric E III |
VP of Sales |
|
2006-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
41,071 |
|
- |
|
Cote Ulric E III |
VP of Sales |
|
2006-12-12 |
4 |
D |
$0.00 |
$72 |
D/D |
(24,000) |
17,071 |
|
- |
|
Sinclair Edward |
VP Clinical Research, Regulat |
|
2006-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
36,000 |
36,000 |
|
- |
|
Sinclair Edward |
VP Clinical Research, Regulat |
|
2006-12-12 |
4 |
D |
$0.00 |
$108 |
D/D |
(36,000) |
0 |
|
- |
|
Lichtwardt Gregory |
Executive Vice President, CFO |
|
2006-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
36,000 |
37,500 |
|
- |
|
Lichtwardt Gregory |
Executive Vice President, CFO |
|
2006-12-12 |
4 |
D |
$0.00 |
$108 |
D/D |
(36,000) |
1,500 |
|
- |
|
Sieczkarek Mark M |
President/CEO |
|
2006-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
72,000 |
72,000 |
|
- |
|
264 Records found
|
|
Page 7 of 11 |
|
|